LATAM Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.

Press releases published on July 6, 2026

Jul. 6, 2026

KPIT Deploys its Next-Generation Mobility Intelligence Product Across Multiple OEMs

Indeterminate EIN Presswire

Jul. 6, 2026

CertiProf 2026 Index: ChatGPT and Copilot Lock in Tight Three-Way Tie for GenAI Market Dominance

Indeterminate EIN Presswire

Jul. 6, 2026

PLEXIS Addresses Revenue Reconciliation and Operational Readiness for Complex Medicare-Medicaid Administration

Indeterminate EIN Presswire

Jul. 6, 2026

AIGIP Introduces Credential for AI Governance, a Skill Still in Short Supply

Indeterminate EIN Presswire

Jul. 6, 2026

Equinox Gold Announces Sale of Shares of Versamet Royalties

Indeterminate GlobeNewswire

Jul. 6, 2026

Cloudastructure Strengthens Balance Sheet with Elimination of Variable Conversion Debt Feature and Provides Update on First Quarter 2026 Filing

Indeterminate GlobeNewswire

Jul. 6, 2026

SalesCloser Technologies to Commence Trading on the OTCQB Venture Market

Indeterminate GlobeNewswire

Jul. 6, 2026

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

Indeterminate GlobeNewswire

Jul. 6, 2026

Bilan semestriel du Contrat de Liquidité de DBV Technologies avec ODDO BHF

Indeterminate GlobeNewswire

Jul. 6, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

SEALSQ Corp Reports Preliminary H1 2026 Results; Revenue up 120%, FY 2026 Guidance Reaffirmed

Indeterminate GlobeNewswire

Jul. 6, 2026

Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax Announces Closing of $920 Million Public Offering

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax annonce la réalisation de son offre au public de 920 millions de dollars

Indeterminate GlobeNewswire

Jul. 6, 2026

Sprout Social to Announce Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 6, 2026

Longeveron® Appoints Marie Washburn as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 6, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

Indeterminate GlobeNewswire

Jul. 6, 2026

Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection

Indeterminate GlobeNewswire

Jul. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire